MedStar posted operating revenues of $1.5 billion in the third quarter of fiscal year 2020, an increase from the $1.4 billion in revenue posted in the same period one year prior.
The health system saw expenses rise in the quarter to $1.4 billion, up about 4 percent from the same quarter in fiscal 2019.
MedStar recorded operating income of $32.2 million in the third quarter of fiscal 2020. This compares to an operating income of $41.4 million in the same quarter of fiscal 2019.
In the quarter, MedStar posted a $274.9 million investment loss, driven by the unstable markets amid the COVID-19 pandemic.
After factoring in other nonoperating losses and a tax income benefit, the system posted a net loss of $246.8 million in the quarter ended March 31. In the same period last year, the system recorded a net income of $172 million.
MedStar said that the COVID-19 pandemic resulted in lower patient volume and reduced revenue in the third quarter, and it expects a “significant negative impact on revenues and operating results in the fourth quarter of fiscal year 2020.”
More articles on healthcare finance:
U of Vermont Medical Center furloughs about 450 employees
Montefiore loses $96.7M in Q1: 5 things to know
UPMC’s net loss hits $653M in Q1, driven by pandemic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
